Veletri and Hypercapnia - a phase IV clinical study of FDA data

Summary:

Hypercapnia is reported as a side effect among people who take Veletri (epoprostenol sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Hypercapnia when taking Veletri. It is created by eHealthMe based on reports of 14,192 people who have side effects when taking Veletri from the FDA, and is updated regularly.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.

What is Hypercapnia?

Hypercapnia (too much smoke) is found to be associated with 462 drugs and 654 conditions by eHealthMe. Check the latest studies of Hypercapnia.

On Aug, 11, 2026

14,192 people reported to have side effects when taking Veletri.
Among them, 20 people (0.14%) have Hypercapnia.

Among these 20 people:

How long have people been on Veletri when they have Hypercapnia? *

What is the gender of people who have Hypercapnia when taking Veletri? *

female: 80 %
male: 20 %

What is the age of people who have Hypercapnia when taking Veletri? *

What are other drugs people take besides Veletri? *

What are other side effects people have besides Hypercapnia? *

Dyspnea Exertional: 15 people, 75.00%
Chest Pain: 15 people, 75.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 14 people, 70.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 14 people, 70.00%
Dizziness: 14 people, 70.00%
Dyspnea (difficult or laboured breathing): 14 people, 70.00%
Fluid Overload (too much fluid in the blood): 13 people, 65.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 13 people, 65.00%
Weight Increased: 12 people, 60.00%
Diarrhea: 11 people, 55.00%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 85.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 10.00%
Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Veletri and have Hypercapnia?

- Check whether Hypercapnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Veletri:

Veletri (14,196 reports)

Hypercapnia treatments and more:

Hypercapnia (3,855 reports)

Browse all side effects of Veletri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercapnia:

Hypercapnia (462 drugs)

Browse all the conditions that are associated with Hypercapnia:

Hypercapnia (654 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoprostenol sodium (the active ingredients of Veletri) and Veletri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.